Does minoxidil really work for women’s hair loss?
Yes—topical minoxidil is the only FDA-approved medicine for female pattern hair loss. Up to 60% of patients regrow noticeably thicker hair after eight months of daily use (2% solution twice daily or 5% foam once daily). Consistency and early treatment are key; for best results, always consult a clinician first.
Evidence for Topical Minoxidil Use in Women
Clinical trials established minoxidil’s efficacy in women with female pattern hair loss (FPHL):
- In clinical studies that led to the FDA approval of minoxidil 2% solution, 19% of women reported moderate hair regrowth (and 40% reported minimal regrowth) after 8 months compared to 7% of women using a placebo.
- In a 32-week, double-blind, placebo-controlled trial, 2% minoxidil solution led to new hair growth in 60% of women, compared to 40% in the placebo group.
- A 48-week study found that 5% topical minoxidil was superior to both placebo and 2% minoxidil, with greater patient-perceived benefit but a slightly higher risk of irritation and unwanted hair growth.
- A 2016 systematic review found evidence to support topical minoxidil for the treatment of female pattern hair loss.
Which Strength and Formulation?
Choosing the right strength and formulation of minoxidil (brand name: Women's Rogaine) is an important step in achieving the best results for women’s hair loss. With options ranging from the original 2% solution to the newer 5% foam, and even oral formulations for select cases, understanding the differences can help tailor treatment to individual needs, preferences, and tolerances.
- 2% Solution: The original FDA-approved formulation, applied twice daily, remains a first-line, over-the-counter option.
- 5% Foam: FDA-approved for once-daily use in women, the foam is often better tolerated (less dripping, easier application) and may offer slightly better regrowth.
- Oral Minoxidil: Not FDA-approved for hair loss but sometimes prescribed off-label (0.25 to 1.25 mg daily) for women who do not respond to topical treatment. Oral minoxidil requires medical supervision due to a higher risk of systemic side effects.
How to Use Minoxidil Correctly
Minoxidil comes in different formulations over the counter, such as a topical solution and foam. The foam is indicated for once-daily use, whereas the solution is recommended to be applied twice a day. Below is a general guide on how to apply minoxidil correctly, but make sure to always follow the directions on your specific minoxidil product or from your healthcare provider.
Step-by-step guide:
- Apply the amount specified on the package or by your healthcare provider to the hair loss areas on a dry scalp, parting hair to reach thinning areas.
- Wash your hands well after applying.
- Allow the solution or foam to dry before styling or bedtime. This may take a few hours for the solution, while the foam tends to dry faster.
- Expect increased shedding in the first 4–6 weeks—this is temporary.
- Assess results at six months; continued use is necessary to maintain benefits.
When Will You See Results?
Everyone responds differently to minoxidil treatment. However, most people tend to follow the following timeline:
- 1-3 weeks: Temporary shedding of old, thin hair to make room for new hair growth.
- Month 2-4: You may notice soft baby hairs growing in.
- Month 4-6: Thicker, fuller hair is noticeable.
- After 6 months: Continue use to maintain hair regrowth and prevent hair loss.
Safety and Side Effects
Most side effects of minoxidil occur near the area where it is applied, and may include itching, scalp irritation, rash, temporary hair shedding, and unwanted facial hair. Systemic side effects are rare with topical use of minoxidil, but dizziness, low blood pressure, and rapid heartbeat are possible.
Because of the potential for minoxidil to cause harm to babies, it is not recommended for pregnant or breastfeeding women.
Who Should (and Should Not) Use Minoxidil
Not everyone is an ideal candidate for minoxidil, and using it safely means understanding who should—and should not—consider this treatment. While minoxidil is FDA-approved for women 18 and older with hereditary hair thinning on the scalp, certain health conditions, life stages, and scalp issues can make its use unsafe or ineffective.
- Good candidates: Women aged 18 and over with early or moderate female-pattern hair loss.
- Use caution/avoid: Pregnant or breastfeeding women, those with active scalp infections, uncontrolled hypertension, or known hypersensitivity to minoxidil.
Your healthcare provider can discuss the risks and benefits of using minoxidil for hair loss with you and help you determine if it is the best treatment option.
Advantages and Disadvantages of Minoxidil for Hair Loss
Like most medications, there are pros and cons to using minoxidil for hair loss.
Pros
- Over the counter
- Proven to be effective for hair loss in women
- Different formulations available, including a once-daily foam option
- Works for many hair types
Cons
- Lifelong commitment required
- Full results take 6-12 months
- Risk of irritation or unwanted facial hair
- Limited efficacy in advanced balding
Alternatives and Adjunct Treatments for Hair Loss
While minoxidil is the only FDA-approved topical treatment for female-pattern hair loss, it’s not the only option available. For women who don’t respond to minoxidil, experience side effects, or want to maximize results, several alternative and adjunct therapies exist. These range from oral medications to innovative procedures and at-home devices—each with its own evidence base, benefits, and considerations.
- Low-level laser therapy: Safe and effective for some women.
- Spironolactone: Off-label anti-androgen, often used if minoxidil fails.
- Oral finasteride/dutasteride: Off-label use, but may be considered in some women.
- Platelet-rich plasma (PRP) or microneedling: Emerging options with promising results, but neither are FDA approved for hair loss.
Key Takeaways
- Minoxidil is the only FDA-approved topical treatment for female-pattern hair loss.
- Both 2% solution (twice daily) and 5% foam (once daily) are effective; foam may be easier to use.
- Visible improvement takes 6–12 months and is lost if treatment stops.
- Always consult a healthcare professional, especially before considering oral minoxidil.
This is not all the information you need to know about minoxidil for safe and effective use and does not take the place of your doctor’s directions. Review the full patient medication guide and discuss this information and any questions you have with your doctor or other health care provider.
References
- Aleissa M. (2023). The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Cureus, 15(8), e43559. https://doi.org/10.7759/cureus.43559
- Avci P, Gupta GK, Clark J, Wikonkal N, Hamblin MR. Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med. 2014 Feb;46(2):144-51. doi: 10.1002/lsm.22170. Epub 2013 Aug 23. PMID: 23970445; PMCID: PMC3944668.
- Boersma, I. H., Oranje, A. P., Grimalt, R., Iorizzo, M., Piraccini, B. M., & Verdonschot, E. H. (2014). The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. Indian journal of dermatology, venereology and leprology, 80(6), 521–525. https://doi.org/10.4103/0378-6323.144162
- DeVillez, R. L., Jacobs, J. P., Szpunar, C. A., & Warner, M. L. (1994). Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Archives of dermatology, 130(3), 303–307. PMID: 8129407
- Gogtay, J. A., & Panda, M. (2009). Minoxidil topical foam: a new kid on the block. International journal of trichology, 1(2), 142. https://doi.org/10.4103/0974-7753.58560
- Gupta, A. K., Quinlan, E. M., Venkataraman, M., & Bamimore, M. A. (2022). Microneedling for Hair Loss. Journal of cosmetic dermatology, 21(1), 108–117. https://doi.org/10.1111/jocd.14525
- Harvard Health Publishing. (n.d.). Treating female pattern hair loss. Accessed on June 26, 2025 at https://www.health.harvard.edu/staying-healthy/treating-female-pattern-hair-loss
- Kobayashi, S., Rose, L., Minta, A., Trovato, S., & Dulmage, B. (2025). Comparing Adherence, Side Effects, and Satisfaction in Oral and Topical Minoxidil: A Cross-Sectional Study. Journal of drugs in dermatology : JDD, 24(2), 131–133. https://doi.org/10.36849/JDD.8424
- Iamsumang, W., Leerunyakul, K., & Suchonwanit, P. (2020). Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. Drug design, development and therapy, 14, 951–959. https://doi.org/10.2147/DDDT.S240615
- Lachgar, S., Charveron, M., Gall, Y., & Bonafe, J. L. (1998). Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells. The British journal of dermatology, 138(3), 407–411. https://doi.org/10.1046/j.1365-2133.1998.02115.x
- Lucky, A. W., Piacquadio, D. J., Ditre, C. M., Dunlap, F., Kantor, I., Pandya, A. G., Savin, R. C., & Tharp, M. D. (2004). A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology, 50(4), 541–553. https://doi.org/10.1016/j.jaad.2003.06.014
- Müller Ramos, P., Melo, D. F., Radwanski, H., de Almeida, R. F. C., & Miot, H. A. (2023). Female-pattern hair loss: therapeutic update. Anais brasileiros de dermatologia, 98(4), 506–519. https://doi.org/10.1016/j.abd.2022.09.006
- Nobari NN, Roohaninasab M, Sadeghzadeh-Bazargan A, et al. 2023. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia. Adv Clin Exp Med. https://doi.org/10.17219/acem/157990
- Paichitrojjana, A., & Paichitrojjana, A. (2022). Platelet Rich Plasma and Its Use in Hair Regrowth: A Review. Drug design, development and therapy, 16, 635–645. https://doi.org/10.2147/DDDT.S356858
- Patel P, Nessel TA, Kumar D D. Minoxidil. [Updated 2023 Feb 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Accessed on June 26, 2025 at https://www.ncbi.nlm.nih.gov/books/NBK482378/
- Ramírez-Marín, H. A., & Tosti, A. (2022). Role of Oral Minoxidil in Patterned Hair Loss. Indian dermatology online journal, 13(6), 729–733. https://doi.org/10.4103/idoj.idoj_246_22
- Rogaine. Frequently Asked Questions. Accessed on June 26, 2025 at https://www.rogaine.com/collections/womens-products
- U. S. Food and Drug Administration. 2021. Microneedling Devices: Getting to the Point on Benefits, Risks and Safety. Accessed on June 26, 2025 at https://www.fda.gov/consumers/consumer-updates/microneedling-devices-getting-point-benefits-risks-and-safety
- van Zuuren, E. J., Fedorowicz, Z., & Schoones, J. (2016). Interventions for female pattern hair loss. The Cochrane database of systematic reviews, 2016(5), CD007628. https://doi.org/10.1002/14651858.CD007628.pub4
- Wall, D., Meah, N., Fagan, N., York, K., & Sinclair, R. (2022). Advances in hair growth. Faculty reviews, 11, 1. https://doi.org/10.12703/r/11-1
- Womens Rogaine Unscented - minoxidil foam [package insert]. Updated November 2024. Kenvue Brands LLC. Accessed on June 26, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d328537-b7f5-43cc-9837-c5a0c6c390f8
- Womens Rogaine Unscented - minoxidil solution [package insert]. Updated September 2024. Kenvue Brands LLC. Accessed on June 26, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf0000c-95f3-4a4d-830b-f5ac1539823d
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Caplyta
Caplyta is used to treat schizophrenia or depression associated with bipolar disorder. It is taken ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Inderal
Inderal (propranolol) is used to treat angina, high blood pressure and heart rhythm disorders ...
Ajovy
Ajovy (fremanezumab-vfrm) is a preventive migraine treatment. Includes Ajovy side effects ...
Vyepti
Vyepti (eptinezumab-jjmr) is used for the preventive treatment of migraine. Includes Vyepti ...
Botox Cosmetic
Botox Cosmetic is a prescription treatment for fine lines and wrinkles. It temporarily improves the ...
Fremanezumab
Fremanezumab is used for chronic migraine, headache, migraine, migraine prevention
Related medical questions
Drug information
- Minoxidil Information for Consumers
- Minoxidil prescribing info & package insert (for Health Professionals)
- Side Effects of Minoxidil (detailed)
- Minoxidil user reviews (10)
Related support groups
- Minoxidil (10 questions, 71 members)